EUVIMEDEUVIMED entdecken
Crossref

Macrocytosis in Mitochondrial DNA Deletion Syndromes

Farida Almarzooqi, Hilary Vallance, Michelle Mezei, Anna Lehman, Gabriella Horvath, Bojana Rakic, Leslie Zypchen, Andre Mattman

Acta Haematologica · 2023 · 146 (3) · 220-225

DOI: 10.1159/000529311 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Acta Haematologica, online erschienen am 10.02.2023. Verfasst von Farida Almarzooqi und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Medicine, University of British Colombia, Vancouver, British Columbia, Canada. Hauptthemen laut MEDLINE: Anemia, Ophthalmoplegia, Ophthalmoplegia, Chronic Progressive External. Die Arbeit wurde bisher 4-mal zitiert (Crossref).

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Large single mitochondrial DNA (mtDNA) deletion syndrome is a rare inborn error of metabolism with variable heteroplasmy levels and clinical phenotype among affected individuals. Chronic progressive external ophthalmoplegia (CPEO) is the most common phenotype in adults with this form of mitochondrial disease [J Intern Med. 2020;287(6):592–608 and Biomed Rep. 2016;4(3):259–62]. The common CPEO clinical manifestations are ptosis and ophthalmoplegia. More variable phenotypic manifestations of CPEO (CPEO plus) include involvement of the peripheral nervous system and myopathy. Here, we describe a 62-year-old female with CPEO and the major mtDNA deletion present at 40% heteroplasmy, who had a coexistent previously undescribed CPEO phenotypic feature of persistent unexplained macrocytosis without anemia. Building on this case, we reviewed other major mtDNA deletion cases seen in our Adult Metabolic Diseases Clinic (AMDC) at the University of British Columbia, Vancouver, Canada, from 2016 to 2022. The major mtDNA deletion cases (n = 26) were compared with mtDNA missense variants identified in the clinic over the same period who acted as the comparison group (n = 16). Of these, the most frequent diagnosis was maternally inherited diabetes and deafness and mitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes. Ten out of 26 (38%) of mtDNA deletion patients had macrocytosis with elevated mean corpuscular volume (MCV), median (interquartile range) of 108 fL (102–114 fL). Seven of the patients with macrocytosis had no pertinent etiology. None of the comparison group had macrocytosis. There was a significant difference (p = 0.000) between the MCV and MCH in the mtDNA deletion group compared to the comparison group. This communication sheds light on the association of macrocytosis with the mtDNA deletion syndrome. It would be of great interest to determine if the association is found in other mitochondrial disease clinic populations.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

AnemiaOphthalmoplegiaOphthalmoplegia, Chronic Progressive ExternalFemaleHumansDNA, MitochondrialDeafnessDiabetes Mellitus, Type 2Mitochondrial Diseases

Stichwörter der Autor:innen

Chronic progressive external ophthalmoplegiaMacrocytosisMaternally inherited diabetes and deafnessMitochondrial DNA deletion syndromesMitochondrial encephalomyopathy with lactic acidosis and stroke-like episodes

Substanzen

DNA, Mitochondrial

Autor:innen und Institutionen

  • Department of Medicine, University of British Colombia, Vancouver, British Columbia, Canada.
  • Department of Pediatrics, College of Medicine and Health Sciences, UAE University, Al Ain, United Arab Emirates.
  • Department of Pathology and Laboratory Medicine, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Adult Metabolic Diseases Clinic, Vancouver General Hospital and Division of Neurology, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Department of Medical Genetics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.
  • Division of Biochemical Diseases, Department of Pediatrics, Faculty of Medicine, University of British Columbia, Vancouver, British Columbia, Canada.

Zitieren

APA

Almarzooqi, F., Vallance, H., Mezei, M., Lehman, A., Horvath, G., Rakic, B., Zypchen, L., & Mattman, A. (2023). Macrocytosis in Mitochondrial DNA Deletion Syndromes. Acta Haematologica, 146(3), 220-225. https://doi.org/10.1159/000529311

Vancouver

Almarzooqi F, Vallance H, Mezei M, Lehman A, Horvath G, Rakic B, et al. Macrocytosis in Mitochondrial DNA Deletion Syndromes. Acta Haematologica. 2023;146(3):220-225. doi:10.1159/000529311

BibTeX
@article{Almarzooqi2023,
  author = {Almarzooqi, Farida and Vallance, Hilary and Mezei, Michelle and Lehman, Anna and Horvath, Gabriella and Rakic, Bojana and Zypchen, Leslie and Mattman, Andre},
  title = {Macrocytosis in Mitochondrial DNA Deletion Syndromes},
  journal = {Acta Haematologica},
  year = {2023},
  volume = {146},
  number = {3},
  pages = {220--225},
  doi = {10.1159/000529311}
}
Kostenlos starten →